Novavax
NVAX
NVAX
323 hedge funds and large institutions have $1.74B invested in Novavax in 2022 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 94 increasing their positions, 102 reducing their positions, and 105 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
30% less capital invested
Capital invested by funds: $2.48B → $1.74B (-$742M)
48% less first-time investments, than exits
New positions opened: 55 | Existing positions closed: 105
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
323
Holding in Top 10
–
Calls
$373M
Puts
$434M
Top Buyers
| 1 | +$41.8M | |
| 2 | +$25.6M | |
| 3 | +$24.2M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$22.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$19.7M |
Top Sellers
| 1 | -$52.9M | |
| 2 | -$51M | |
| 3 | -$27.6M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$21.7M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$19.1M |